Home
/
ACRO BIOMEDICAL CO., LTD.
/
Financials
/
Quarterly
ACRO BIOMEDICAL CO., LTD. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ACRO BIOMEDICAL CO., LTD. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 10, 2025
Q2
2025
Jun 30, 2025
$0
Aug 5, 2025
Q1
2025
Mar 31, 2025
$0
Jul 24, 2025
Q3
2025
Sep 30, 2024
$0
Nov 10, 2025
Q2
2025
Jun 30, 2024
$0
Aug 5, 2025
Q1
2025
Mar 31, 2024
$0
Jul 24, 2025
Q3
2024
Sep 30, 2023
$0
Jul 23, 2025
Q2
2024
Jun 30, 2023
$0
Jul 23, 2025
Q1
2024
Mar 31, 2023
$0
Jul 22, 2025
Q3
2023
Sep 30, 2022
$0
Jul 11, 2025
Q2
2023
Jun 30, 2022
$0
Aug 14, 2023
Q1
2023
Mar 31, 2022
$298.5K
Aug 2, 2023
Q1
2022
Mar 31, 2021
$99.5K
May 16, 2022
Q2
2018
Mar 31, 2018
$1.96M
Aug 1, 2018
Q1
2018
Dec 31, 2017
$1.45M
Feb 14, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($117.8K)
Nov 10, 2025
Q3
2025
Jun 30, 2025
($15.6K)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($15.6K)
Aug 5, 2025
Q3
2025
Mar 31, 2025
($10.3K)
Nov 10, 2025
Q2
2025
Mar 31, 2025
($10.3K)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($10.3K)
Jul 24, 2025
Q3
2025
Sep 30, 2024
($10.2K)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($10.1K)
Aug 5, 2025
Q3
2025
Jun 30, 2024
($10.1K)
Nov 10, 2025
Q1
2025
Mar 31, 2024
($11.3K)
Jul 24, 2025
Q2
2025
Mar 31, 2024
($11.3K)
Aug 5, 2025
Q3
2025
Mar 31, 2024
($11.3K)
Nov 10, 2025
Q3
2024
Sep 30, 2023
($1.59M)
Jul 23, 2025
Q2
2024
Jun 30, 2023
($3.20M)
Jul 23, 2025
Q3
2024
Jun 30, 2023
($3.20M)
Jul 23, 2025
Q1
2024
Mar 31, 2023
($4.00M)
Jul 22, 2025
Q2
2024
Mar 31, 2023
($4.00M)
Jul 23, 2025
Q3
2024
Mar 31, 2023
($4.00M)
Jul 23, 2025
Q3
2023
Sep 30, 2022
($4.01M)
Jul 11, 2025
Q2
2023
Jun 30, 2022
($4.00M)
Aug 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($115.1K)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($13.6K)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($8.9K)
Jul 24, 2025
Q3
2025
Sep 30, 2024
($9.1K)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($9.1K)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($10.3K)
Jul 24, 2025
Q3
2024
Sep 30, 2023
($1.59M)
Jul 23, 2025
Q2
2024
Jun 30, 2023
($3.19M)
Jul 23, 2025
Q1
2024
Mar 31, 2023
($4.00M)
Jul 22, 2025
Q3
2023
Sep 30, 2022
($4.01M)
Jul 11, 2025
Q2
2023
Jun 30, 2022
($4.00M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($3.93M)
Aug 2, 2023
Q3
2022
Sep 30, 2021
($2.99M)
Nov 21, 2022
Q2
2022
Jun 30, 2021
($793.3K)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($57.0K)
May 16, 2022
Q3
2021
Sep 30, 2020
($71.5K)
Nov 22, 2021
Q2
2021
Jun 30, 2020
($62.8K)
Aug 23, 2021
Q1
2021
Mar 31, 2020
$81.6K
May 24, 2021
Q3
2020
Sep 30, 2019
($64.5K)
Nov 17, 2020
Q2
2020
Jun 30, 2019
($68.1K)
Aug 19, 2020